2021 annual financial data
Taysha Gene Therapies 2021 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -173,267,000 USD and net income was -174,523,000 USD.
Operating cash flow was -117,042,000 USD.
Get free Taysha Gene Therapies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -173,267,000 USD
- Net income
- -174,523,000 USD
- Operating cash flow
- -117,042,000 USD